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Bacteremia Caused by Laribacter hongkongensis Misidentified as 
Acinetobacter lwoffii: Report of the First Case in Korea
Laribacter hongkongensis is an emerging pathogen in patients with community-acquired 
gastroenteritis and traveler’s diarrhea. We herein report a case of L. hongkongensis 
infection in a 24-yr-old male with liver cirrhosis complicated by Wilson’s disease. He was 
admitted to a hospital with only abdominal distension. On day 6 following admission, he 
complained of abdominal pain and his body temperature reached 38.6°C. The results of 
peritoneal fluid evaluation revealed a leukocyte count of 1,180/µL (polymorphonuclear 
leukocyte 74%). Growth on blood culture was identified as a gram-negative bacillus. The 
isolate was initially identified as Acinetobacter lwoffii by conventional identification 
methods in the clinical microbiology laboratory, but was later identified as L. hongkongensis 
on the basis of molecular identification. The patient was successfully treated with 
cefotaxime. To the best of our knowledge, this case is the first report of hospital-acquired 
L. hongkongensis bacteremia with neutrophilic ascites.
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INTRODUCTION
Laribacter hongkongensis is a facultative anaerobic, motile, non-
sporulating gram-negative bacillus. It belongs to the family Neis-
seriaceae of the β subclass of Proteobacteria (1). Since the first 
description of L. hongkongensis from the blood and empyema 
pus of a patient with alcoholic liver cirrhosis in 2001, the bacte-
rium has subsequently been associated with community-ac-
quired gastroenteritis (1, 2). However, accurate identification of 
L. hongkongensis is impossible using commercially-available 
phenotypic identification systems. Thus, the prevalence, patho-
genic potential, and epidemiology of L. hongkongensis are un-
clear. The identification based on a molecular approach could 
permit more accurate determinations of incidence and evalua-
tion of clinical relevance. 
  Although L. hongkongensis has been reported in Hong Kong, 
China, and Hungary (3), it has not hitherto been identified in 
Korea. Recently, we experienced a case of L. hongkongensis bac-
teremia with neutrophilic ascites. The bacterium was originally 
misidentified as Acinetobacter lwoffii. Proper identification was 
achieved using a molecular approach. 
CASE DESCRIPTION
A 24-yr-old male was admitted to a hospital, on August 16, 2007, 
with a 15-day history of abdominal distension. The patient had 
been diagnosed with Wilson’s disease at 17-yr-of-age and had 
since undergone treatment for liver cirrhosis complicated by 
Wilson’s disease. The patient had no history of overseas travel 
and had no recall of ingesting undercooked freshwater fish for 
at least the previous year. On physical examination, blood pres-
sure was 98/49 mmHg, pulse rate was 96 beats per min, and 
body temperature (36.5°C). All measurements were within the 
normal range. Abdominal examination revealed a diffusely dis-
tended abdomen, diminished bowel sound, and splenomegaly. 
Laboratory tests revealed a hemoglobin concentration of 8.3 g/
dL, leukocyte count of 6,248/μL, platelet count of 42,000/μL, se-
rum creatinine level of 0.94 mg/dL, serum bilirubin level of 6.7 
mg/dL, and serum albumin level of 1.6 g/dL. The analysis of peri-
toneal fluid demonstrated an albumin level of 202 mg/dL and 
leukocyte count of 130/μL (poly 15%). Dose adjustment of diuret-
ics was done to control ascites. The patient’s subsequent hospi-
tal course was uneventful. But, on day 6 following admission, 
fever developed, with a body temperature reaching 38.6°C. Ex-Kim DS, et al.  •  Laribacter hongkongensis Bacteremia
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amination showed diffuse tenderness of the entire abdomen. 
The results of peritoneal fluid evaluation revealed a leukocyte 
count of 1,180/μL (poly 74%). Empirical treatment with cefotax-
ime (2 g every 8 hr) was commenced with a presumptive diagno-
sis of spontaneous bacterial peritonitis. Two days later, growth 
on blood culture was identified as a gram-negative bacillus us-
ing the BacT ALERT 3D culture system. The isolate was desig-
nated 07AC-292. However, no organism was identified in the 
peritoneal fluid. The patient responded to cefotaxime and was 
discharged on post-admission day 12.
  To identify isolate 07AC-292, biochemical characterization 
by VITEK2 with an ID-GNB card was performed in accordance 
with the manufacturer’s instructions. The isolate was identified 
as A. lwoffii at a confidence level of 94%. However, an Acineto-
bacter differentiation method using the rpoB gene (4) indicated 
that the isolate did not belong to the genus Acinetobacter. Thus, 
we tried to identify isolate 07AC-292 accurately using a molecu-
lar method. The DNA of the isolate was extracted and a portion 
of the 16S rRNA gene was amplified and sequenced using the 
primer set as previously described (5). A 1,346-bp sequence was 
obtained. The determined sequences were compared with the 
GenBank public database using the BLASTn program (http://
blast.ncbi.nlm.nih.gov/Blast.cgi). The 16S rRNA sequence of the 
isolate 07AC-292 showed complete identity with several L. hon-
gkongensis strains in the database. Thus, isolate 07AC-292 was 
definitively identified as L. hongkongensis. A phylogenetic tree 
constructed based on 16S rRNA gene sequences also supported 
the identity of isolate 07AC-292 as L. hongkongensis (Fig. 1). 
  Antibiotic susceptibility testing (ampicillin-sulbactam, ce-
fepime, ceftriaxone, ceftazidime, amikacin, cefoperazone-sul-
bactam, imipenem, meropenem, doripenem, tetracycline, cip-
rofloxacin, rifampin, piperacillin-tazobactam, colistin, polymyx-
in B, and tigecycline) was conducted using the broth microdi-
lution method according to Clinical and Laboratory Standards 
Institute (CLSI) protocol (6). Minimum inhibitory concentration 
breakpoints and quality-control protocols were used according 
to non-fermenting gram-negative organism guidelines estab-
lished by the CLSI. Isolate 07AC-292 was resistant to piperacil-
lin, intermediate resistant to ceftriaxon, and susceptible to the 
other tested antibiotics (Table 1). 
DISCUSSION
L. hongkongensis was first isolated from a 54-yr-old Chinese male 
with alcoholic cirrhosis and thoracic bacateremic empyema (1, 
2). Subsequently, the bacterium has been isolated from patients 
in other parts of the world. The isolation of L. hongkongensis 
from patients who are residents in, or recent travelers to, Asia, 
Europe, America, and Africa imply the global importance of the 
bacterium (7). Most reported cases were associated with recent 
travel and eating fish and symptoms are similar to salmonella 
and campylobacter gastroenteritis (2). Although freshwater fish 
is probably a major reservoir of L. hongkongensis, differences 
exist between isolates obtained from humans and fish using 
pulsed-field gel electrophoresis, suggesting that not all environ-
mental clones are virulent (8).
  The presently-reported patient, who had underlying liver cir-
rhosis associated with Wilson’s disease, was suffering from neu-
trophilic ascites caused by L. hongkongensis. In contrast to pre-
vious described cases, the patient denied a history of ingestion 
of undercooked freshwater fish and overseas travel. It may be 
that the infection was hospital-acquired. Previous studies report-
ed that this bacterium was associated with community-acquired 
gastroenteritis and traveler’s diarrhea (2). It has been suggested 
that there was no carriage state of L. hongkongenesis (8), although 
Table 1. Minimum inhibitory concentrations (MICs) of the isolate 07AC-292 in the 
antimicrobial susceptibility testing
Antimicrobial agent MIC (mg/L) Resistance*
Ampicillin/sulbactam 4/2 S
Cefepime   8 S
Ceftriaxone 32 I
Ceftazidime   8 S
Amikacin   8 S
Cefoperazone-sulbactam 8/4 -
Imipenem 0.06 S
Meropenem 0.06 S
Doripenem 0.06 S
Tetracycline 0.06 S
Ciprofloxacin 0.06 S
Rifampin   2 S
Piperacillin-tazobactam > 256/4 R
Colistin   4 S
Polymyxin B   2 S
Tigecycline 0.06 S
*Since no validated interpretative criteria are available for L. hongkongnsis, the CLSI 
breakpoints for Acinetobacter spp. were used to determine susceptibilities (6). R, 
resistant; I, intermediate; S, susceptible.
Fig. 1. Phylogenetic relationships of 07AC-292 and other species of the most similar 
sequences, retrieved from GenBank, based on partial 16S rRNA gene sequences. This 
unrooted tree was constructed by method of neighbor-joining. Numbers at branching 
nodes are percentages of 1,000 bootstrap replications. 
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the gastrointestinal tract has been suggested as a possible pri-
mary site of infection and enteric bacteria could enter the sys-
temic circulation from the portal vein by passage through the 
liver in patients with portal hypertension (1, 2). The present L. 
hongkongensis infection may have originated from the intesti-
nal flora. If so, it indicates that L. hongkongensis may exist in a 
carriage state in his intestine flora. In someone suffering from 
liver cirrhosis, the result could be a debilitating infection.
  To date, all L. hongkongensis strains tested have been resistant 
to ampicillin and cephalosporins, but susceptible to the carbap-
enems, amoxicillin-clavulanate, aminoglycosides and fluoro-
quinolones (9). The isolate in this study showed a somewhat 
different antibiotic susceptibility profile, in that it was suscepti-
ble to ampicillin-sulbactam and several cephalosporins. A com-
parative study among L. hongkongensis isolates could more pre-
cisely determine the difference antibiotic susceptibility profiles, 
indicative of different origins. 
  To our knowledge, this case is the first report of hospital-ac-
quired L. hongkongensis bacteremia with neutrophilic ascites. 
So far, no rapid and accurate commercial phenotypic identifi-
cation exists for L. hongkongensis. Thus, L. hongkongensis could 
be frequently misidentified as other species. Isolate 07AC-292 
was initially misidentified as A. lwoffii. Such misidentification 
might occur because L. hongkongensis is not included in the da-
tabase of commercial identification systems and biochemical 
tests are not enough to differentiate it from other species. Thus, 
it is conceivable that more L. hongkongensis infections have oc-
curred, but have not been accurately identified due to the lack 
of proper identification tools. Since multidrug-resistant Acineto-
bacter sp. isolates are increasing in Korea and L. hongkongensis 
is susceptible to most antimicrobial agents, correct identification 
of L. hongkongensis may reduce the inappropriate use of anti-
microbial agents. Further clinical experiences with invasive dis-
eases caused by L. hongkongensis are necessary to evaluate its 
potential pathogenesis. Extensive epidemiologic studies should 
be carried out to ascertain the etiologic association between L. 
hongkongensis and the intestinal normal flora, and to identify 
the host and the routes of transmission of L. hongkongensis. 
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